NDA 017105 · Ajenat Pharms
Tranxene
Clorazepate Dipotassium · Oral
NovelLast checked: Nov 20, 2026Latest source record: Jan 13, 2023 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1972
Jun 23, 1972
Approved uses
2
Original approval plus efficacy supplements
Registered trials
4
1 Phase 3, 0 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jan 29, 1981 Supplement 39 · Efficacy
- Jun 23, 1972 Original approval · Type 1 - New Molecular Entity
8 products under this application
- TRANXENE · CLORAZEPATE DIPOTASSIUM 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, ORAL · Discontinued
- TRANXENE · CLORAZEPATE DIPOTASSIUM 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, ORAL · Discontinued
- TRANXENE SD · CLORAZEPATE DIPOTASSIUM 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, ORAL · Discontinued
- TRANXENE · CLORAZEPATE DIPOTASSIUM 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CAPSULE, ORAL · Discontinued
- TRANXENE · CLORAZEPATE DIPOTASSIUM 7.5MG · TABLET, ORAL · Prescription · TE AB
- TRANXENE SD · CLORAZEPATE DIPOTASSIUM 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, ORAL · Discontinued
- TRANXENE · CLORAZEPATE DIPOTASSIUM 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CAPSULE, ORAL · Discontinued
- TRANXENE · CLORAZEPATE DIPOTASSIUM 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CAPSULE, ORAL · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Clorazepate Dipotassium" as an intervention, any sponsor and status, largest first.
- Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency RoomPivotal-lookingTerminated
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT04726592 · 323 participants · Start Jul 8, 2021 · Primary completion Apr 10, 2024
Drug: Clorazepate Dipotassium; Placebo and 2 more · For: Migraine; Migraine Without Aura; Migraine With Aura and 1 more
Sites: Paris, France
- Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major DepressionPivotal-lookingTerminated
Hospital Universitari de BellvitgeAcademic, hospital or other
NCT01305707 · 104 participants · Start Jul 2009 · Primary completion Jul 2014
Drug: PHARMACOTHERAPY · For: Depression
Sites: Barcelona, Spain; L'Hospitalet de Llobregat, Spain; Sabadell, Spain
- Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell LymphomasPivotal-lookingTerminated
Polish Lymphoma Research GroupResearch network
NCT02323659 · 100 participants (planned) · Start Jun 1, 2014 · Primary completion Mar 2018
Drug: Methotrexate; Interferon Alfa-2b · For: Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
Sites: Bydgoszcz, Poland
Ranbaxy Laboratories LimitedIndustry
NCT00775996 · 32 participants · Start Aug 2003 · Primary completion Sep 2003
Drug: Clorazepate Dipotassium 15mg Tablets · For: Healthy
Sites: Lincoln, Nebraska
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Effects of clorazepate dipotassium and placebo on psychomotor skills.
Moodley P, Golombok S, Lader M · Percept Mot Skills 1985 · Clinical Trial, Randomized Controlled Trial
- Clorazepate dipotassium in anxiety: a clinical trial with diazepam and placebo controls.
Ricca JJ · J Clin Pharmacol New Drugs 1972 · Clinical Trial, Comparative Study
- Controlled trial of dipotassium clorazepate ("Tranxene") in anxiety.
Cooper AJ, Magnus RV, Rose M, et al. · Br J Psychiatry 1973 · Clinical Trial, Comparative Study
- A controlled comparative trial of clorazepate (Tranxene) and diazepam (Valium) for anxiety.
Burrows GD, Dumovic P, Smith JA, et al. · Med J Aust 1977 · Clinical Trial, Comparative Study
- Desmethyldiazepam kinetics after intravenous, intramuscular, and oral administration of clorazepate dipotassium.
Ochs HR, Steinhaus E, Locniskar A, et al. · Klin Wochenschr 1982 · Clinical Trial, Randomized Controlled Trial
- Clorazepate (tranxene). Another benzodiazepine.
· Med Lett Drugs Ther 1972 · Clinical Trial, Controlled Clinical Trial
Sponsor: Ajenat Pharms · Also marketed as Tranxene Sd
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.